Clinical Trials in Burgos, Castille and León
8 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Metastatic Colorectal Cancer
Amgen450 enrolled286 locationsNCT06252649
Recruiting
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Genitourinary Cancers
Spanish Oncology Genito-Urinary Group500 enrolled84 locationsNCT06724159
Recruiting
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
AstraZeneca4,490 enrolled138 locationsNCT06252753
Recruiting
Phase 2
Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma
Large B-cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea80 enrolled15 locationsNCT07126236
Recruiting
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Advanced CancerMelanoma Stage IVMelanoma Stage III
Grupo Español Multidisciplinar de Melanoma400 enrolled39 locationsNCT03605771
Recruiting
Neck Evolution With Ovation in Spain
Abdominal Aortic Aneurysm
DGM Vascular120 enrolled9 locationsNCT05823519
Recruiting
Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)
PregnancyInflammatory Bowel Diseases
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa1,750 enrolled73 locationsNCT03894228